ELTROMBOPAG OLAMINE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA.
ELTROMBOPAG OLAMINE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA.
Synthetic
Hematology
| EU DMF | |
| US DMF |
2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid